Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Extrapolating from our experience delivering a "boost" field of radiation concurrently with fields treating both gross and subclinical disease at the end of a course of radiation therapy, we developed a regimen to deliver concurrent chemotherapy during the last 2 weeks of a conventionally fractionated course of radiation.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Clin. Oncol.

Title: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ISSN: 0732-183X

ISSN (Print): 0732-183X

Publication date (Electronic): Aug 1999

Volume: 17

Issue: 8

Affiliations

[1 ] Departments of Radiation Oncology, Thoracic Head and Neck Medical Oncology, and Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. agarden@notes.mdacc.tmc.edu

Article

DOI: 10.1200/jco.1999.17.8.2390

PubMed ID: 10561301

SO-VID: 0e171f7b-ec22-44ae-abe6-27f62101ca7d

History

Data availability:

Comments

Comment on this article

scite_

Cited by 1

Phase I Trial of Radiotherapy Concurrent with Twice-Weekly Gemcitabine for Head and Neck Cancer: Translation From Preclinical Investigations Aiming to Improve the Therapeutic Ratio12
Authors: Aron Popovtzer, Daniel P. Normolle, Francis Worden …

See all cited by